Peer-Reviewed Research
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4–10). Current research has investigated Semax in laboratory, animal, and translational neuroscience models involving neuroprotection, ischemic stroke, traumatic brain injury, oxidative stress, Alzheimer's disease, spinal cord injury, and neuroinflammation. Although Semax has a longer clinical history in Russia, relatively few recent international human clinical trials have been published. Much of the current literature remains preclinical. (pubmed.ncbi.nlm.nih.gov)
Original Research
Semax peptide targets the μ opioid receptor gene Oprm1 to promote functional recovery after spinal cord injury
Journal: British Journal of Pharmacology
Published: 2025
Study Type: Original preclinical research
Summary
Researchers evaluated Semax in a mouse model of spinal cord injury. Treatment improved neurological recovery, reduced neuronal damage, and identified Oprm1 as a potential molecular target associated with functional recovery. The findings support continued investigation of Semax in experimental neuroregeneration but do not establish efficacy in humans.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/40692165/
Semax decreases copper-catalyzed reactive oxygen species production and amyloid-β cytotoxicity
Journal: Bioinorganic Chemistry and Applications
Published: 2025
Study Type: Original laboratory research
Summary
This laboratory investigation evaluated Semax in Alzheimer's disease–related experimental models. Researchers reported reductions in copper-mediated oxidative stress and decreased amyloid-β cytotoxicity through mechanisms involving metal-ion interactions. The study provides mechanistic insight into Semax's neuroprotective activity but was not performed in human participants.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/40496623/
The effect of Semax on intracellular calcium dynamics in rat brain neurons
Journal: Bulletin of Experimental Biology and Medicine
Published: 2025
Study Type: Original laboratory research
Summary
Researchers investigated how Semax influenced intracellular calcium signaling in rat hippocampal neurons. The findings demonstrated changes in calcium dynamics associated with neuronal signaling pathways involved in cellular function and neuroprotection. Additional studies are required to determine the clinical significance of these findings.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/41171324/
Semax affects copper-induced amyloid-β aggregation in artificial membrane models
Journal: ACS Chemical Neuroscience
Published: 2022 (Landmark Study)
Study Type: Original laboratory research
Summary
This mechanistic study demonstrated that Semax reduced copper-induced amyloid-β aggregation and associated cytotoxicity in experimental membrane models. The findings remain an important reference for understanding Semax's proposed neuroprotective mechanisms.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/35080861/
Review Articles
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Journal: International Journal of Molecular Sciences
Published: 2026
Study Type: Scientific review
Summary
This review discusses investigational therapeutic peptides used across neurological, metabolic, endocrine, and regenerative research. Semax is included among neuroactive peptides currently being investigated, while the authors emphasize the need for additional high-quality clinical trials before therapeutic conclusions can be drawn.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/42123471/
Injectable Peptides in Sports Medicine: A Structured Narrative Review
Published: 2026
Study Type: Scientific review
Summary
This review summarizes current evidence surrounding several investigational peptides. It distinguishes laboratory findings from established human clinical evidence and highlights the limited number of randomized clinical trials available for many neuroactive peptides, including Semax.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/42160466/
Additional Semax Publications
Browse current PubMed research:
https://pubmed.ncbi.nlm.nih.gov/?term=Semax
Research Disclaimer
The information presented in this Research Library is provided for educational and scientific reference purposes only and is based on published peer-reviewed research. Research findings continue to evolve, and investigational compounds may not be approved for clinical use. All Pearland Peptides products are supplied For Research Use Only and are not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease.